All patients with systemic sclerosis require screening for interstitial lung disease, PAH

SAN DIEGO — All patients with systemic sclerosis should be screened for pulmonary arterial hypertension and interstitial lung disease, according to a speaker at the 2024 Congress of Clinical Rheumatology West.
“This is a rare disease, and most rheumatologists only see about 10 or 12 scleroderma patients in a year,” Janet E. Pope, MD, MPH, FRCPC, professor of medicine at the University of Western Ontario, in London, Canada, told attendees. “So how do I predict who I’m supposed to worry about? When I go home at night, who do I worry about?”
According to what

SAN DIEGO — All patients with systemic sclerosis should be screened for pulmonary arterial hypertension and interstitial lung disease, according to a speaker at the 2024 Congress of Clinical Rheumatology West.
“This is a rare disease, and most rheumatologists only see about 10 or 12 scleroderma patients in a year,” Janet E. Pope, MD, MPH, FRCPC, professor of medicine at the University of Western Ontario, in London, Canada, told attendees. “So how do I predict who I’m supposed to worry about? When I go home at night, who do I worry about?”
According to what